Boehm AL[au] - Search Results

Year	Number of Results
2003	1
2007	3
2008	2
2009	1
2010	1
2022	2
2023	0

1

Addressing Diversity, Equity, and Inclusion at the JNCI Journals.

Ganz PA, Chen RC, Boehm AL. Ganz PA, et al. Among authors: boehm al. J Natl Cancer Inst. 2022 Sep 9;114(9):1207-1208. doi: 10.1093/jnci/djac124. J Natl Cancer Inst. 2022. PMID: 36065087 Free PMC article. No abstract available.

2

STAT-mediated EGFR signaling in cancer.

Quesnelle KM, Boehm AL, Grandis JR. Quesnelle KM, et al. Among authors: boehm al. J Cell Biochem. 2007 Oct 1;102(2):311-9. doi: 10.1002/jcb.21475. J Cell Biochem. 2007. PMID: 17661350 Review.

3

Addressing Diversity, Equity, and Inclusion at the JNCI Journals.

Ganz PA, Chen RC, Boehm AL. Ganz PA, et al. Among authors: boehm al. JNCI Cancer Spectr. 2022 Sep 1;6(5):pkac046. doi: 10.1093/jncics/pkac046. JNCI Cancer Spectr. 2022. PMID: 36065091 Free PMC article. No abstract available.

4

Nanoprecipitation technique for the encapsulation of agrochemical active ingredients.

Boehm AL, Martinon I, Zerrouk R, Rump E, Fessi H. Boehm AL, et al. J Microencapsul. 2003 Jul-Aug;20(4):433-41. doi: 10.1080/0265204021000058410. J Microencapsul. 2003. PMID: 12851043

5

Concurrent vaccination with two distinct vaccine platforms targeting the same antigen generates phenotypically and functionally distinct T-cell populations.

Boehm AL, Higgins J, Franzusoff A, Schlom J, Hodge JW. Boehm AL, et al. Cancer Immunol Immunother. 2010 Mar;59(3):397-408. doi: 10.1007/s00262-009-0759-7. Epub 2009 Sep 16. Cancer Immunol Immunother. 2010. PMID: 19756595 Free PMC article.

6

Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses.

Wansley EK, Chakraborty M, Hance KW, Bernstein MB, Boehm AL, Guo Z, Quick D, Franzusoff A, Greiner JW, Schlom J, Hodge JW. Wansley EK, et al. Among authors: boehm al. Clin Cancer Res. 2008 Jul 1;14(13):4316-25. doi: 10.1158/1078-0432.CCR-08-0393. Clin Cancer Res. 2008. PMID: 18594015 Free PMC article.

7

Antiproliferative mechanisms of a transcription factor decoy targeting signal transducer and activator of transcription (STAT) 3: the role of STAT1.

Lui VW, Boehm AL, Koppikar P, Leeman RJ, Johnson D, Ogagan M, Childs E, Freilino M, Grandis JR. Lui VW, et al. Among authors: boehm al. Mol Pharmacol. 2007 May;71(5):1435-43. doi: 10.1124/mol.106.032284. Epub 2007 Feb 26. Mol Pharmacol. 2007. PMID: 17325127

8

Targeting antiapoptotic Bcl-2 family members with cell-permeable BH3 peptides induces apoptosis signaling and death in head and neck squamous cell carcinoma cells.

Li R, Boehm AL, Miranda MB, Shangary S, Grandis JR, Johnson DE. Li R, et al. Among authors: boehm al. Neoplasia. 2007 Oct;9(10):801-11. doi: 10.1593/neo.07394. Neoplasia. 2007. PMID: 17971900 Free PMC article.

9

Combined targeting of epidermal growth factor receptor, signal transducer and activator of transcription-3, and Bcl-X(L) enhances antitumor effects in squamous cell carcinoma of the head and neck.

Boehm AL, Sen M, Seethala R, Gooding WE, Freilino M, Wong SM, Wang S, Johnson DE, Grandis JR. Boehm AL, et al. Mol Pharmacol. 2008 Jun;73(6):1632-42. doi: 10.1124/mol.107.044636. Epub 2008 Mar 6. Mol Pharmacol. 2008. PMID: 18326051 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year